(Q47886236)

6 February 2018

title

Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332. (English)

1 reference

6 February 2018

main subject

immunization

0 references

Plasmodium falciparum

1 reference

Andersson C

1

1 reference

6 February 2018

Vasconcelos NM

2

1 reference

6 February 2018

Sievertzon M

3

1 reference

6 February 2018

Haddad D

4

1 reference

6 February 2018

Liljeqvist S

5

1 reference

6 February 2018

Berglund P

6

1 reference

6 February 2018

Liljeström P

7

1 reference

6 February 2018

Ahlborg N

8

1 reference

6 February 2018

Ståhl S

9

1 reference

6 February 2018

Berzins K

10

1 reference

6 February 2018

publication date

1 July 2001

1 reference

6 February 2018

Scandinavian Journal of Immunology

published in

1 reference

6 February 2018

volume

54

1 reference

6 February 2018

issue

1-2

1 reference

6 February 2018

page(s)

117-124

1 reference

6 February 2018

DNA and RNA-based vaccines: principles, progress and prospects

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Self-replicating Semliki Forest virus RNA as recombinant vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Enhancing immune responses using suicidal DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

DNA immunization with Plasmodium falciparum serine repeat antigen: regulation of humoral immune response by coinoculation of cytokine expression plasmid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Characterization of antibody responses to a Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Differential induction of immunoglobulin G subclasses by immunization with DNA vectors containing or lacking a signal sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Biology of giant proteins of Plasmodium: resolution on polyacrylamide-agarose composite gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Pfl I-I and Pf332: two giant proteins synthesized in erythrocytes infected with Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Epitope specificity and capacity to inhibit parasite growth in vitro of human antibodies to repeat sequences of the Plasmodium falciparum antigen Ag332.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Inhibition of in vitro growth of plasmodium falciparum field isolates mediated by human antibodies to Pf155/RESA and Pf332.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

The Pf332 gene of Plasmodium falciparum codes for a giant protein that is translocated from the parasite to the membrane of infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

pUR 250 allows rapid chemical sequencing of both DNA strands of its inserts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Predominance of H-2d- and H-2k-restricted T-cell epitopes in the highly repetitive Plasmodium falciparum antigen Pf332.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Mammalian cell production of a respiratory syncytial virus (RSV) candidate vaccine recovered using a product-specific affinity column

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Overcoming codon bias: a method for high-level overexpression of Plasmodium and other AT-rich parasite genes in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Polynucleotide vaccines in animals: enhancing and modulating responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00951.X

10.1046/J.1365-3083.2001.00951.X

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018